Creating genetically modified bacteria involves designing a piece of DNA with desired traits, physically inserting it into bacterial cells, and then identifying which cells successfully took up the new genetic material. The core process has been used since the 1970s, but modern tools like CRISPR have made it faster and more precise. Whether the goal is producing human insulin or studying basic biology, the same fundamental steps apply.
Designing the DNA to Insert
Before anything enters a bacterial cell, researchers need to build the DNA construct they want to introduce. This usually means isolating a gene of interest and placing it into a small, circular piece of DNA called a plasmid. Plasmids act as delivery vehicles because bacteria naturally carry and replicate them alongside their own chromosome.
Two key molecular tools make this assembly possible. Restriction enzymes act as molecular scissors, recognizing specific short sequences in DNA and cutting at those exact spots. Different restriction enzymes cut at different sequences, so researchers pick the ones that will snip out their gene of interest and open up the plasmid at the right location. The cuts often leave short, single-stranded overhangs called “sticky ends” that can pair up with matching overhangs on another piece of DNA.
Once the gene fragment and the opened plasmid are mixed together, their sticky ends link up through normal base pairing. An enzyme called DNA ligase then seals the breaks, bonding the pieces into a single, unbroken loop of DNA. The result is a recombinant plasmid: the original plasmid now carrying the new gene, ready for delivery into bacteria.
Getting DNA Into Bacterial Cells
Bacterial cell membranes don’t normally let large DNA molecules pass through. Researchers use several methods to overcome this barrier, and the choice depends on the bacterial species, the size of the DNA, and the efficiency needed.
Heat Shock Transformation
The most common lab method is heat shock transformation. First, bacteria are made “competent,” meaning their membranes are primed to accept foreign DNA. This is typically done by bathing the cells in ice-cold calcium chloride solution (around 100 millimolar concentration), which neutralizes the negative charges on both the cell membrane and the DNA so they don’t repel each other. The cells are grown at 37°C until they reach a specific density, then chilled on ice for 20 to 30 minutes in the calcium chloride solution.
Once the competent cells are mixed with the plasmid DNA and kept on ice for another 20 to 30 minutes, the actual transformation happens through a brief temperature shock. The tube is plunged into a 42°C water bath for 30 to 60 seconds (45 seconds is typical), then immediately returned to ice for 2 minutes. This rapid temperature swing creates temporary pores in the membrane that allow DNA to slip inside. The whole process takes under an hour and requires no specialized equipment beyond a water bath and ice.
Electroporation
For larger DNA constructs or bacterial species that don’t respond well to heat shock, electroporation is the alternative. A brief, high-voltage electrical pulse is applied to cells suspended in a small cuvette, creating temporary holes in the membrane. This method tends to be more efficient and can handle bigger pieces of DNA, but it requires an electroporator device and cells prepared without the salts used in chemical methods.
Conjugation
Some bacteria can transfer DNA directly to one another through a process called conjugation. A donor cell builds a physical bridge to a recipient cell, either through a hair-like pilus (in species like E. coli) or through surface proteins. Single-stranded DNA passes through this channel from one cell to the other. Researchers exploit conjugation when working with bacterial species that are difficult to transform by other methods, using a well-characterized donor strain to deliver engineered DNA into the target organism.
Identifying Successfully Modified Cells
Not every cell in a transformation takes up the new DNA. In a typical experiment, the vast majority of bacteria remain unchanged. Researchers need a reliable way to separate the modified cells from the unmodified ones, and they use two layers of screening to do this.
The first layer is a selectable marker, almost always an antibiotic resistance gene built into the plasmid. After transformation, the entire batch of bacteria is spread on growth plates containing that antibiotic. Only cells carrying the plasmid (and therefore the resistance gene) survive. Every colony that grows on the plate has the plasmid inside it.
The second layer confirms that the gene of interest actually made it into the plasmid, since some plasmids may have re-sealed without incorporating the new gene. One classic method is blue-white screening. The plasmid contains a gene that produces a blue pigment when active. The gene of interest is inserted into the middle of this pigment gene, disrupting it. Colonies that appear white on the plate contain the recombinant plasmid with the inserted gene. Blue colonies have an intact pigment gene, meaning the plasmid closed back up without the insert. Picking white colonies gives researchers a high-confidence starting pool of correctly modified bacteria.
Editing Genes With CRISPR
Traditional cloning inserts new genes on a plasmid that exists alongside the bacterial chromosome. CRISPR-Cas9 allows researchers to edit the chromosome itself, changing, deleting, or inserting sequences at precise locations within the bacterium’s own genome.
The system works in three steps. First, a short guide RNA is designed to match the exact chromosomal sequence the researcher wants to modify. This guide RNA pairs with its target through normal base pairing, directing the Cas9 protein to the right spot. Second, Cas9 cuts both strands of the DNA at that location, creating a clean break. Third, the cell’s own repair machinery fixes the break. If no template is provided, the repair process often introduces small errors that disable the gene. If the researcher supplies a template DNA sequence, the cell can use it as a blueprint, allowing precise insertions or replacements at the cut site.
CRISPR has largely replaced older methods for making targeted chromosomal changes because it requires only a new guide RNA sequence for each target, rather than building entirely new genetic constructs.
Growing Modified Bacteria at Scale
Once a correctly modified colony is confirmed, the next challenge is growing enough of it to be useful. In a research lab, this might mean a flask on a shaker. For industrial applications, it means bioreactors holding tens or hundreds of liters.
Scale-up typically uses fed-batch fermentation, where nutrients are added gradually rather than all at once. Researchers monitor pH, dissolved oxygen, and nutrient concentrations throughout the growth cycle. Cell density is tracked to determine when to harvest or when to move to a larger vessel. The process is staged: a small starter culture seeds a medium-sized bioreactor, which then seeds a larger one. At each stage, the culture needs to reach sufficient density before moving to the next.
Human insulin production illustrates this pipeline. The gene for human proinsulin is expressed in E. coli BL21, a workhorse lab strain optimized for protein production. The bacteria are grown in 20-liter fed-batch fermentation. The proinsulin accumulates inside the cells as dense protein clumps called inclusion bodies, which are then isolated, dissolved, and refolded into the correct three-dimensional shape. Enzymes trim the proinsulin into its active form. This same basic workflow, with variations in the gene and processing steps, produces dozens of pharmaceutical proteins, industrial enzymes, and research reagents.
Safety and Containment Requirements
Work with genetically modified bacteria operates under strict biosafety guidelines. In the United States, the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules lay out containment procedures based on the risk level of the organism and the inserted genes. Most routine genetic modification of harmless lab strains like E. coli takes place at Biosafety Level 1 (BSL-1), which requires standard lab practices like handwashing and surface decontamination. Work involving organisms that could pose moderate risks to people operates at BSL-2, where spills or accidental exposures must be reported to the institution’s biosafety committee. Higher containment levels (BSL-3 and BSL-4) apply to modifications involving dangerous pathogens, with mandatory immediate reporting of any potential exposure incidents to federal oversight bodies.
Every institution conducting this work maintains an Institutional Biosafety Committee that reviews proposed experiments before they begin, assessing risks and ensuring proper containment is in place. The goal is straightforward: keep modified organisms inside the lab and prevent unintended release into the environment.
Synthetic Biology and Minimal Genomes
The most ambitious frontier in bacterial modification isn’t adding genes but stripping them away. Researchers have worked for decades to determine the smallest possible genome that can sustain a living, self-replicating cell. The landmark achievement came with JCVI-syn3.0, a synthetic bacterium containing just 473 genes, built through four rounds of design, construction, and testing. For comparison, E. coli carries around 4,300 genes.
The team started with existing data on which genes were essential, designed a hypothetical minimal genome of about 471 genes, then built it in segments that could be swapped in and out of a working cell. Testing revealed that roughly 240 genes were strictly essential, 432 were non-essential, and 229 fell into a gray zone where removing them caused growth problems of varying severity. After progressively trimming non-essential genes across multiple cycles, the final organism had about half the genome of the starting strain. Intriguingly, about a third of the genes in this minimal cell have no known function, meaning they’re clearly necessary for life but scientists don’t yet understand why.
Minimal cells like this serve as a blank canvas. By starting with the simplest possible organism, researchers can add genes one at a time and study their effects in isolation, or build custom bacteria designed from the ground up for specific industrial or medical tasks.